Keyphrases
Structure-activity Relationship
100%
Receptor Targets
100%
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Targeting Peptide
100%
Targeted Tumor Therapy
100%
HER2 Receptor
100%
Breast Cancer
25%
Pharmacokinetics
25%
Transmembrane
25%
High Affinity
25%
High Specificity
25%
Drug Target
25%
Flow Cytometry
25%
Extracellular Region
25%
Breast Cancer Cell Lines
25%
Confocal Microscopy
25%
Patient Outcomes
25%
Expression Profile
25%
Secondary Structure Prediction
25%
Fluorescently Labeled
25%
Specific Peptide
25%
Simple Synthesis
25%
High Mortality Rate
25%
HER2 Expression
25%
Human Epidermal Growth Factor
25%
Receptor Recognition
25%
HER2 Overexpression
25%
Tyrosine Kinase Receptor
25%
Valuable Objects
25%
Extracellular Localization
25%
Tumor-targeting Peptide
25%
Helical Content
25%
HER2+ Breast Cancer
25%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Epidermal Growth Factor
100%
Conjugate
100%
Protein Secondary Structure
100%
Confocal Microscopy
100%
Mortality Rate
100%
Drug Targeting
100%
Tyrosine Kinase Receptor
100%
Flow Cytometry
100%
Medicine and Dentistry
Cancer Therapy
100%
Receptor
100%
Neoplasm
50%
Breast Cancer
50%
Mortality Rate
50%
Conjugate
50%
Breast Cancer Cell Line
50%
Side Effect
50%
Confocal Microscopy
50%
Gamma Urogastrone
50%
Protein Secondary Structure
50%
Flow Cytometry
50%
Drug Delivery System
50%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
50%
Tyrosine Kinase Receptor
50%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Receptor
100%
Breast Cancer
66%
Side Effect
33%
Mortality Rate
33%
Drug Delivery System
33%
Flow Cytometry
33%
Confocal Microscopy
33%
Gamma Urogastrone
33%
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer
33%
Tyrosine Kinase Receptor
33%